193
Participants
Start Date
March 31, 2015
Primary Completion Date
September 30, 2015
Study Completion Date
February 29, 2016
MYL-1401H
During each chemotherapy cycle MYL-1401H (6 mg) is administered s.c. 24 hours after chemotherapy.
Neulasta
During each chemotherapy cycle Neulasta (6 mg) is administered s.c. 24 hours after chemotherapy.
Mylan Investigational Site 3502, Plovdiv
Mylan Investigational Site 3506, Plovdiv
Mylan Investigational Site 3507, Plovdiv
Mylan Investigational Site 3503, Sofia
Mylan Investigational Site 3505, Sofia
Mylan Investigational Site 3504, Varna
Mylan Investigational SIte 3501, Veliko Tarnovo
Mylan Investigational Site 9901, Tbilisi
Mylan Investigational Site 9902, Tbilisi
Mylan Investigational Site 9903, Tbilisi
Mylan Investigational Site 9904, Tbilisi
Mylan Investigational Site 9905, Tbilisi
Mylan Investigational Site 9906, Tbilisi
Mylan Investigational Site 9907, Tbilisi
Mylan Investigational site 4905, Bonn
Mylan Investigational Site 3604, Budapest
Mylan Investigational SIte 3606, Budapest
Mylan Investigational Site 3607, Budapest
Mylan Investigational Site 3609, Debrecen
Mylan Investigational Site 3601, Gyula
Mylan Investigational SIte 3605, Nyíregyháza
Mylan Investigational Site 3603, Szombathely
Mylan Investigational Site 3602, Zalaegerszeg
Mylan Investigational site 4802, Bydgoszcz
Mylan Investigational Site 4805, Kościerzyna
Mylan Investigational SIte 4804, Krakow
Mylan Investigational SIte 3804, Chernivtsi
Mylan Investigational site 3801, Dniepropetrovsk
Mylan Investigational Site 3805, Dniepropetrovsk
Mylan Investigational Site 3808, Kharkiv
Mylan Investigational Site 3810, Kyiv
Mylan Investigatational Site 3802, Lutsk
Mylan Investigational SIte 3807, Lviv
Mylan Investigational SIte 3803, Odesa
Mylan Investigational Site 3809, Sumy
Mylan Investigational Site 3806, Uzhhorod
Lead Sponsor
Mylan GmbH
INDUSTRY
Mylan Inc.
INDUSTRY